EUVIMEDEUVIMED entdecken
Crossref

Pregnancy and Lactation Evidence Across the FDA CDER Novel Drug Lifecycle: A Descriptive Study of Public Documentation for Drugs Approved 2015–2023

Chengliang Wang, Yan Zhang, Guoping Zhang, Jing Tang, Li Chen, Xiting Tang

Therapeutic Innovation & Regulatory Science · 15.11.2026

DOI: 10.1007/s43441-026-01071-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Innovation & Regulatory Science, online erschienen am 15.11.2026. Verfasst von Chengliang Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: People's Hospital of Ganzi Tibetan Autonomous Prefecture, Kangding, 626000, Sichuan, China. Die Arbeit nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Drug labelingFDA CDERLactationPostmarketing requirementsPregnancyRegulatory science

Autor:innen und Institutionen

  • People's Hospital of Ganzi Tibetan Autonomous Prefecture, Kangding, 626000, Sichuan, China.
  • Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China. chenl_hxey@scu.edu.cn.
  • Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China. chenl_hxey@scu.edu.cn.
  • Department of Pharmacology, Faculty of Medicine and Nursing, University of the Basque Country, Leioa, Spain. chenl_hxey@scu.edu.cn.
  • People's Hospital of Ganzi Tibetan Autonomous Prefecture, Kangding, 626000, Sichuan, China. 13734526@qq.com.

Zitieren

APA

Wang, C., Zhang, Y., Zhang, G., Tang, J., Chen, L., & Tang, X. (2026). Pregnancy and Lactation Evidence Across the FDA CDER Novel Drug Lifecycle: A Descriptive Study of Public Documentation for Drugs Approved 2015–2023. Therapeutic Innovation & Regulatory Science. https://doi.org/10.1007/s43441-026-01071-2

Vancouver

Wang C, Zhang Y, Zhang G, Tang J, Chen L, Tang X. Pregnancy and Lactation Evidence Across the FDA CDER Novel Drug Lifecycle: A Descriptive Study of Public Documentation for Drugs Approved 2015–2023. Therapeutic Innovation & Regulatory Science. 2026. doi:10.1007/s43441-026-01071-2

BibTeX
@article{Wang2026,
  author = {Wang, Chengliang and Zhang, Yan and Zhang, Guoping and Tang, Jing and Chen, Li and Tang, Xiting},
  title = {Pregnancy and Lactation Evidence Across the FDA CDER Novel Drug Lifecycle: A Descriptive Study of Public Documentation for Drugs Approved 2015–2023},
  journal = {Therapeutic Innovation & Regulatory Science},
  year = {2026},
  doi = {10.1007/s43441-026-01071-2}
}
Kostenlos starten →